Literature DB >> 28209792

How Common Is Residual Inflammatory Risk?

Paul M Ridker1.   

Abstract

Keywords:  C-reactive protein; atherosclerosis; cholesterol; inflammation; prevention

Mesh:

Substances:

Year:  2017        PMID: 28209792     DOI: 10.1161/CIRCRESAHA.116.310527

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  30 in total

1.  Admission Low-Density Lipoprotein Cholesterol Stratified by Circulating CD14++CD16+ Monocytes and Risk for Recurrent Cardiovascular Events Following ST Elevation Myocardial Infarction: Lipid Paradox Revised.

Authors:  Shaozhuang Dong; Wenjie Ji; Shan Zeng; Jun Miao; Lifang Yan; Xinlin Liu; Junxiang Liu; Xin Zhou; Qing Yang
Journal:  J Cardiovasc Transl Res       Date:  2020-06-18       Impact factor: 4.132

Review 2.  n-3 Polyunsaturated Fatty Acids and Cardiovascular Disease: Principles, Practices, Pitfalls, and Promises - A Contemporary Review.

Authors:  Richard Kones; Scott Howell; Umme Rumana
Journal:  Med Princ Pract       Date:  2017-11-29       Impact factor: 1.927

Review 3.  Visceral Adipose Tissue Accumulation and Residual Cardiovascular Risk.

Authors:  Thierry H Le Jemtel; Rohan Samson; Gregory Milligan; Abhishek Jaiswal; Suzanne Oparil
Journal:  Curr Hypertens Rep       Date:  2018-07-10       Impact factor: 5.369

Review 4.  Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis

Authors:  Paul M Ridker
Journal:  Circ Res       Date:  2019-02       Impact factor: 17.367

5.  Highlighting Residual Atherosclerotic Cardiovascular Disease Risk.

Authors:  Yunosuke Matsuura; Jenny E Kanter; Karin E Bornfeldt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-01       Impact factor: 8.311

6.  High-sensitivity C-reactive protein levels and health status outcomes after myocardial infarction.

Authors:  Yashashwi Pokharel; Puza P Sharma; Mohammed Qintar; Yuan Lu; Yuanyuan Tang; Philip Jones; Rachel P Dreyer; John A Spertus
Journal:  Atherosclerosis       Date:  2017-09-18       Impact factor: 5.162

Review 7.  Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond.

Authors:  Peter Libby
Journal:  J Am Coll Cardiol       Date:  2017-10-31       Impact factor: 24.094

Review 8.  Perivascular Adipose Tissue and Coronary Atherosclerosis: from Biology to Imaging Phenotyping.

Authors:  Andrew Lin; Damini Dey; Dennis T L Wong; Nitesh Nerlekar
Journal:  Curr Atheroscler Rep       Date:  2019-11-19       Impact factor: 5.113

Review 9.  Lipoprotein-associated phospholipase A2: The story continues.

Authors:  Fubao Huang; Kai Wang; Jianhua Shen
Journal:  Med Res Rev       Date:  2019-05-29       Impact factor: 12.944

10.  Cost-effectiveness of Canakinumab for Prevention of Recurrent Cardiovascular Events.

Authors:  Thomas S G Sehested; Jenny Bjerre; Seul Ku; Andrew Chang; Alison Jahansouz; Douglas K Owens; Mark A Hlatky; Jeremy D Goldhaber-Fiebert
Journal:  JAMA Cardiol       Date:  2019-02-01       Impact factor: 14.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.